Answer
Eosinophilic oesophagitis has been reported with Itulazax, and treatment should be interrupted and medical evaluation sought if severe or persistent gastro-oesophageal symptoms, such as difficulty swallowing or indigestion, occur.
Sources for this answer
- ITULAZAX 12 SQ-BetALK-Abello Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 7Document updated
Sources checked